AI Terminal
Ellomay Capital Ltd.
Quarterly Report • Jun 27, 2021
6770_rns_2021-06-27_4a4d445e-9691-4adf-97d9-bbb31d470bac.pdf
Quarterly Report
Open in ViewerOpens in native device viewer
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2021 Commission File Number: 001-35284
Ellomay Capital Ltd.
(Translation of registrant's name into English)
18 Rothschild Blvd., Tel Aviv 6688121, Israel (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
THE IFRS FINANCIAL RESULTS INCLUDED IN EXHIBIT 99.1 OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT'S REGISTRATION STATEMENTS ON FORM F-3 (NOS. 333-199696 AND 333-144171) AND FORM S-8 (NOS. 333-187533, 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
This Report on Form 6-K of Ellomay Capital Ltd. consists of the following document, which is attached hereto and incorporated by reference herein:
Exhibit 99.1 Press Release: "Ellomay Capital Reports Results for the Three Months Ended March 31, 2021," dated June 24, 2021.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Ellomay Capital Ltd.
By: /s/ Ran Fridrich Ran Fridrich Chief Executive Officer and Director
Dated: June 24, 2021
Ellomay Capital Reports Results for the Three Months Ended March 31, 2021
Tel-Aviv, Israel, June 24, 2021 – Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported unaudited financial results for the three month period ended March 31, 2021.
Financial Highlights
- Revenues were approximately €7.2 million for the three months ended March 31, 2021, compared to approximately €1.9 million for the three months ended March 31, 2020. This increase is mainly attributable to the achievement of PAC (Preliminary Acceptance Certificate) of the Talasol photovoltaic facility (the "Talasol PV Plant") on January 27, 2021, upon which the Company commenced recognition of revenues. The increase also resulted from the acquisition of the Groen Gas Gelderland B.V. biogas facility (the "Gelderland Biogas Plant") in December 2020 and improved operational efficiency at the Company's biogas plants in the Netherlands.
- Operating expenses were approximately €3.2 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. Depreciation expenses were approximately €3.1 million for the three months ended March 31, 2021, compared to approximately €0.7 million for the three months ended March 31, 2020. The increase in operating expenses and in depreciation expenses is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
- Project development costs were approximately €0.5 million for the three months ended March 31, 2021, compared to approximately €1.8 million for the three months ended March 31, 2020. The decrease in project development costs is mainly due to capitalization of expenses in connection with the pumped-hydro storage project in the Manara Cliff commencing the fourth quarter of 2020.
- General and administrative expenses were approximately €1.3 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. There was no material change in the composition of the expenses included in general and administrative expenses between the two periods.
- Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €0.6 million for the three months ended March 31, 2021, compared to approximately €1.3 million for the three months ended March 31, 2020. The decrease in the Company's share of profit of equity accounted investee is mainly attributable to the decrease in Dorad Energy Ltd.'s revenues.
- Financing expenses, net were approximately €2.8 million for the three months ended March 31, 2021, compared to approximately €0.4 million for the three months ended March 31, 2020. The increase in financing expenses, net, was mainly attributable to €0.8 million of expenses due to the early repayment of the Company's Series B Debentures and financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC.
- Tax benefits were approximately €0.3 million for the three months ended March 31, 2021, compared to taxes on income of approximately €0.1 million for the three months ended March 31, 2020.
- Loss for the three months ended March 31, 2021 was approximately €2.7 million, compared to a loss of approximately €1.9 million for the three months ended March 31, 2020.
- Total other comprehensive loss was approximately €2.4 million for the three months ended March 31, 2021, compared to other comprehensive income of approximately €14 million for the three months ended March 31, 2020. The decrease in total other comprehensive income mainly resulted from changes in fair value of cash flow hedges.
- Total comprehensive loss was approximately €5 million for the three months ended March 31, 2021, compared to total comprehensive income of approximately €12.1 million for the three months ended March 31, 2020.
- EBITDA was approximately €2.9 million for the three months ended March 31, 2021, compared to EBITDA loss of approximately €(0.6) million for the three months ended March 31, 2020. See the table on page 12 of this press release for a reconciliation of these numbers to profit and loss.
- Net cash provided by operating activities was approximately €1.3 million for the three months ended March 31, 2021, compared to net cash used in operating activities of approximately €0.5 million for the three months ended March 31, 2020. The increase is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
- As of June 1, 2021, the Company held approximately €78 million in cash and cash equivalents and approximately €9.8 million in restricted short-term and long-term cash.
CEO Review – First Quarter of 2021
The financial results for the first quarter of 2021 included first time results of the Talasol PV Plant (300 MW photovoltaic plant in Spain) and the Gelderland Biogas Plant (which has a green gas production license of 7.5 million Nm3 per year). The results of the quarter reflect an increase of approximately 270% in revenues and net cash from operating activities changed from loss in the first quarter of 2020 to profit.
During the first quarter the pumped hydro-storage project in the Manara Cliff, Israel (156MWh with an aggregate storage capacity of approximately 1,900 MWh), achieved financial closing and as of today the building works have commenced. In addition, we received the construction permits for the Ellomay Solar project (28 MW photovoltaic plant in Spain) and the building works are in progress.
In parallel to the operations of the existing portfolio and the management of the projects under construction, the Company is advancing the development of a pipeline of photovoltaic projects in Spain, Italy and Israel, which includes approximately 479 MW in advanced development stages and approximately 850 MW in preliminary development stages.
Talasol PV Plant (300 MW photovoltaic plant in Spain)
The proceeds from sale of electricity during the first quarter were approximately €4.1 and in line with the higher projected revenues for the first quarter of 2021. Based on applicable accounting rules, an amount of approximately €1 million of such proceeds (which represents revenues from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC)) was not recognized as revenues and was capitalized and deducted from the cost of construction. The Adjusted FFO of the Talasol PV Plant for the quarter was approximately €1.8 million (including the period prior to January 27, 2021 of which the results were capitalized in accordance with applicable accounting rules). The efficiency of the Talasol PV Plant during the first quarter of 2021was approximately 88.43%, compared to the constructor's contractual undertaking for a minimal efficiency of 76.95%.
Biogas Segment – the Netherlands
During the first quarter of 2021, the Company successfully completed the integration of the Gelderland Biogas Plant. This plant is equal in size to the two other plants owned by the Company (combined) and is characterized by advanced manufacturing equipment. The existing equipment enables an increase of approximately 20% of production (subject to receipt of required permits) and the plant includes additional land owned by the project company which will enable additional expansion. The biogas segment of the Company produced revenues of approximately €3.1 million and contributed approximately €0.6 million of FFO during the first quarter of 2021. The Company has a plan for additional improvements and enhancements underway that includes improvements in the processes and the expansion of existing facilities.
Photovoltaic Segment in Spain (7.9 MW subsidized by Spain)
The results of these plants for the first quarter of 2021 were in line with the expectations and contributed revenues of approximately €0.8 million and FFO of approximately €0.7 million.
Talmei Yosef PV Plant (9 MW photovoltaic plant in Israel)
The results of the Talmei Yosef PV Plant for the first quarter of 2021 were in line with the expectations and contributed adjusted revenues of approximately €0.8 million (adjusted to present the revenues based on the fixed asset model and not as a financial asset under IFRIC 12) and Adjusted FFO of approximately €0.5 million.
Dorad Power Plant (9.375% indirectly owned by the Company)
The results of the Dorad power plant for the first quarter of 2021 were in line with expectations. The Company's share of the net profit was approximately €0.62 million.
The 2021 first quarter's results of the Company, taking into account the results of the Talasol PV Plant for the period until January 27, 2021 that was not recognized in profit and loss, support the annual projections included in the Company's investor presentation published in May 2021.
The Company's PV operations, including the Talasol PV Plant, are affected by seasonality. The first quarter is characterized by lower radiation resulting in relatively lower revenues. Therefore, the second quarter's revenues of the Company's PV operations are expected to be significantly higher. For example, commencing April 1, 2021 and until today, the Talasol PV Plant produced revenues in the amount of approximately €9 million.
The financing expenses for the quarter included the cost of the early repayment of the Company's Series B debentures and the settlement of the related hedging transactions for an aggregate cost of approximately €1.1 million and its exchange for the Series C debentures that bear a lower interest rate will in the future compensate for the cost of the early repayment.
Use of NON-IFRS Financial Measures
EBITDA, FFO and Adjusted FFO are non-IFRS measures. EBITDA is defined as earnings before financial expenses, net, taxes, depreciation and amortization and FFO (funds from operations) and Adjusted FFO are calculated by adding depreciation and amortization expenses to operating profit (loss) and deducting interest expenses on loans. The Company uses the terms "Adjusted FFO" to highlight the fact that the Company presents the revenues from the Talmei Yosef PV Plant under the fixed asset model and not under IFRIC 12 and includes the financial results of the Talasol PV plant for the period prior to achievement of PAC that were not recognized in the profit and loss statement based on accounting rules. The Company presents these measures in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers these non-IFRS measures to be important measures of comparative operating performance, these non-IFRS measures should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. These non-IFRS measures do not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, are not necessarily indicative of amounts that may be available for discretionary uses. In addition, Adjusted FFO does not represent and is not an alternative to cash flow from operations as defined by IFRS and is not an indication of cash available to fund all cash flow needs, including the ability to make distributions. Not all companies calculate EBITDA, FFO or Adjusted FFO in the same manner, and the measures as presented may not be comparable to similarly-titled measures presented by other companies. The Company's actual EBITDA, FFO and Adjusted FFO may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses these measures internally as performance measures and believes that when these measures are combined with IFRS measures they add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 12 of this press release.
About Ellomay Capital Ltd.
Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.
To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:
- Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
- 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
- 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
- Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
- 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
For more information about Ellomay, visit http://www.ellomay.com.
Information Relating to Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Kalia Weintraub CFO Tel: +972 (3) 797-1111 Email: [email protected] Condensed Consolidated Interim Statements of Financial Position
| March 31 2021 Unaudited |
December 31, 2020 Audited |
March 31, 2021 Unaudited |
|
|---|---|---|---|
| € in thousands | Convenience Translation into US\$ in thousands** |
||
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | 105,020 | 66,845 | 123,249 |
| Marketable securities | - | 1,761 | - |
| Short term deposits | - | 8,113 | - |
| Restricted cash | 2,500 | - | 2,934 |
| Receivable from concession project | 1,533 | 1,491 | 1,799 |
| Trade and other receivables | 9,071 | 9,825 | 10,646 |
| 118,124 | 88,035 | 138,628 | |
| Non-current assets | |||
| Investment in equity accounted investee | 33,229 | 32,234 | 38,997 |
| Advances on account of investments | 2,430 | 2,423 | 2,852 |
| Receivable from concession project | 25,009 | 25,036 | 29,350 |
| Fixed assets | 278,363 | 264,095 | 326,680 |
| Right-of-use asset | 12,473 | 17,209 | 14,638 |
| Intangible asset | 4,552 | 4,604 | 5,342 |
| Restricted cash and deposits | 7,025 | 9,931 | 8,244 |
| Deferred tax | 4,896 | 3,605 | 5,746 |
| Long term receivables | 66 | 2,762 | 77 |
| Derivatives | 5,480 | 10,238 | 6,431 |
| 373,523 | 372,137 | 438,357 | |
| Total assets | 491,647 | 460,172 | 576,985 |
| Liabilities and Equity | |||
| Current liabilities | |||
| Current maturities of long term bank loans Current maturities of long term loans |
13,331 3,549 |
10,232 4,021 |
15,645 4,165 |
| Debentures | 8,295 | 10,600 | 9,735 |
| Trade payables | 2,380 | 12,387 | 2,793 |
| Other payables | 10,232 | 7,912 | 12,008 |
| 37,787 | 44,346 | ||
| 45,152 | |||
| Non-current liabilities | |||
| Lease liability | 12,455 | 17,299 | 14,617 |
| Long-term loans Other long-term bank loans |
151,988 54,015 |
134,520 | 178,369 63,391 |
| Debentures | 92,941 | 49,396 72,124 |
109,073 |
| Deferred tax | 7,982 | 7,806 | 9,367 |
| Other long-term liabilities | 4,351 | 513 | 5,106 |
| Derivatives | 6,308 | 8,336 | 7,403 |
| 330,040 | 289,994 | 387,326 | |
| Total liabilities | 367,827 | 335,146 | 431,672 |
| Equity | 25,578 | 30,018 | |
| Share capital | 25,102 | ||
| Share premium Treasury shares |
85,756 (1,736) |
82,401 (1,736) |
100,641 (2,037) |
| Transaction reserve with non-controlling Interests | 5,145 | 6,106 | 6,038 |
| Reserves | 3,052 | 4,164 | 3,582 |
| Retained earnings | 6,122 | 8,191 | 7,185 |
| Total equity attributed to shareholders of the Company Non-Controlling Interest |
123,917 (97) |
124,228 | 145,427 (114) |
| 798 | |||
| Total equity | 123,820 | 125,026 | 145,313 |
| Total liabilities and equity | 491,647 | 460,172 | 576,985 |
* Convenience translation into US\$ (exchange rate as at March 31, 2021: euro 1 = US\$ 1.174)
Condensed Consolidated Interim Statements of Comprehensive Profit (Loss)
| 2021 Unaudited |
For the three months ended March 31, 2020 |
||||
|---|---|---|---|---|---|
| Audited | Unaudited Convenience Translation into US\$** in |
||||
| € in thousands* | |||||
| Revenues | 7,200 | 1,943 | 9,645 | 8,450 | |
| Operating expenses | (3,217) | (1,061) | (4,951) | (3,775) | |
| Depreciation and amortization | (3,051) | (726) | (2,975) | (3,581) | |
| Gross profit | 932 | 156 | 1,719 | 1,094 | |
| Project development costs | (505) | (1,754) | (3,491) | (593) | |
| General and administrative expenses | (1,263) | (1,081) | (4,512) | (1,482) | |
| Share of profits of equity accounted investee | 617 | 1,331 | 1,525 | 724 | |
| Other expenses, net | - | - | 2,100 | - | |
| Operating loss | (219) | (1,348) | (2,659) | (257) | |
| Financing income | 912 | 425 | 2,134 | 1,070 | |
| Financing income in connection with derivatives, net | (124) | 954 | 1,094 | (146) | |
| Financing expenses | (3,554) | (1,792) | (6,862) | (4,171) | |
| Financing expenses, net | (2,766) | (413) | (3,634) | (3,247) | |
| Loss before taxes on income | (2,985) | (1,761) | (6,293) | (3,504) | |
| Tax benefit (Taxes on income) | 319 | (104) | 125 | 374 | |
| Loss for the period | (2,666) | (1,865) | (6,168) | (3,130) | |
| Loss attributable to: | |||||
| Owners of the Company | (2,069) | (1,417) | (4,627) | (2,428) | |
| Non-controlling interests | (597) | (448) | (1,541) | (702) | |
| Loss for the period | (2,666) | (1,865) | (6,168) | (3,130) | |
| Other comprehensive income (loss) items that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss: |
|||||
| Foreign currency translation differences for foreign operations | 562 | (199) | (482) | 660 | |
| Effective portion of change in fair value of cash flow hedges | (1,929) | 14,112 | 2,210 | (2,264) | |
| Net change in fair value of cash flow hedges transferred to profit or loss | (1,004) | 103 | 555 | (1,178) | |
| Total other comprehensive income (loss) | (2,371) | 14,016 | 2,283 | (2,782) | |
| Total other comprehensive income (loss) attributable to: | |||||
| Owners of the Company | (1,112) | 6,901 | 881 | (1,305) | |
| Non-controlling interests | (1,259) | 7,115 | 1,402 | (1,477) | |
| Total other comprehensive income (loss) for the period | (2,371) | 14,016 | 2,283 | (2,782) | |
| Total comprehensive income (loss) for the period | (5,037) | 12,151 | (3,885) | (5,912) | |
| Total comprehensive income (loss) attributable to: | |||||
| Owners of the Company | (3,181) | 5,484 | (3,746) | (3,733) | |
| Non-controlling interests | (1,856) | 6,667 | (139) | (2,179) | |
| Total comprehensive income (loss) for the period | (5,037) | 12,151 | (3,885) | (5,912) | |
| Basic net loss per share | (0.16) | (0.12) | (0.38) | (0.19) | |
| Diluted net loss per share | (0.16) | (0.12) | (0.38) | (0.19) |
* Except per share data
** Convenience translation into US\$ (exchange rate as at March 31, 2021: euro 1 = US\$ 1.174)
| Attributable to shareholders of the Company | Non controlling Interests |
Total Equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share | Share | Retained | Treasury | Translation reserve from foreign |
Hedging | Interests Transaction reserve with non controlling |
||||
| capital | premium | earnings | shares | operations | Reserve | Interests | Total | |||
| € in thousands | ||||||||||
| For the three month ended March 31, 2021 (unaudited): |
||||||||||
| Balance as at January 1, 2021 | 25,102 | 82,401 | 8,191 | (1,736) | 3,823 | 341 | 6,106 | 124,228 | 798 | 125,026 |
| Loss for the period | - | - | (2,069) | - | - | - | - | (2,069) | (597) | (2,666) |
| Other comprehensive income (loss) | ||||||||||
| for the period | - | - | - | - | 558 | (1,670) | - | (1,112) | (1,259) | (2,371) |
| Total comprehensive income (loss) for the period |
- | - | (2,069) | - | 558 | (1,670) | - | (3,181) | (1,856) | (5,037) |
| Transactions with owners of the Company, recognized directly in equity: |
||||||||||
| Buy of shares in subsidiaries from | ||||||||||
| non-controlling interests | - | - | - | - | - | - | (961) | (961) | 961 | - |
| Warrants exercise | 454 | 3,348 | - | - | - | - | - | 3,802 | - | 3,802 |
| Options exercise | 22 | - | - | - | - | - | - | 22 | - | 22 |
| Share-based payments | - | 7 | - | - | - | - | - | 7 | - | 7 |
| Balance as at | ||||||||||
| March 31, 2021 | 25,578 | 85,756 | 6,122 | (1,736) | 4,381 | (1,329) | 5,145 | 123,917 | (97) | 123,820 |
| Share capital |
Share premium |
Retained earnings |
Treasury shares |
Attributable to shareholders of the Company Translation reserve from foreign operations € in thousands |
Hedging Reserve |
Interests Transaction reserve with non controlling Interests |
Total | Non controlling Interests |
Total Equity |
|
|---|---|---|---|---|---|---|---|---|---|---|
| For the three month ended March 31, | ||||||||||
| 2020 (unaudited): | ||||||||||
| Balance as at January 1, 2020 | 21,998 | 64,160 | 12,818 | (1,736) | 4,356 | (1,073) | 6,106 | 106,629 | 937 | 107,566 |
| Loss for the period | - | - | (1,417) | - | - | - | - | (1,417) | (448) | (1,865) |
| Other comprehensive income (loss) | ||||||||||
| for the period | - | - | - | - | (223) | 7,124 | - | 6,901 | 7,115 | 14,016 |
| Total comprehensive income (loss) for | ||||||||||
| the period | - | - | (1,417) | - | (223) | 7,124 | - | 5,484 | 6,667 | 12,151 |
| Transactions with owners of the Company, recognized directly in equity: |
||||||||||
| Issuance of ordinary shares | 1,935 | 11,253 | - | - | - | - | - | 13,188 | - | 13,188 |
| Share-based payments | - | 14 | - | - | - | - | - | 14 | - | 14 |
| Balance as at March 31, 2020 |
23,933 | 75,427 | 11,401 | (1,736) | 4,133 | 6,051 | 6,106 | 125,315 | 7,604 | 132,919 |
| Attributable to shareholders of the Company | Non controlling Interests |
Total Equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Retained earnings |
Treasury shares |
Translation reserve from foreign operations € in thousands |
Hedging Reserve |
Interests Transaction reserve with non controlling Interests |
Total | |||
| For the year ended | ||||||||||
| December 31, 2020 (Audited): | ||||||||||
| Balance as at January 1, 2020 | 21,998 | 64,160 | 12,818 | (1,736) | 4,356 | (1,073) | 6,106 | 106,629 | 937 | 107,566 |
| Loss for the year | - | - | (4,627) | - | - | - | - | (4,627) | (1,541) | (6,168) |
| Other comprehensive income (loss) for the year |
- | - | - | - | (533) | 1,414 | - | 881 | 1,402 | 2,283 |
| Total comprehensive income (loss) for | ||||||||||
| the year | - | - | (4,627) | - | (533) | 1,414 | - | (3,746) | (139) | (3,885) |
| Transactions with owners of the Company, recognized directly in equity: |
||||||||||
| Issuance of ordinary shares | 3,084 | 18,191 | - | - | - | - | - | 21,275 | - | 21,275 |
| Options exercise | 20 | - | - | - | - | - | - | 20 | - | 20 |
| Share-based payments | - | 50 | - | - | - | - | - | 50 | - | 50 |
| Balance as at | ||||||||||
| December 31, 2020 | 25,102 | 82,401 | 8,191 | (1,736) | 3,823 | 341 | 6,106 | 124,228 | 798 | 125,026 |
| Attributable to shareholders of the Company | Non controlling Interests |
Total Equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Retained earnings |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve |
Interests Transaction reserve with non controlling Interests |
Total | |||
| Convenience translation into US\$ (exchange rate as at March 31, 2021: euro 1 = US\$ 1.174) | ||||||||||
| For the three month ended March 31, 2021 (unaudited): |
||||||||||
| Balance as at January 1, 2021 | 29,459 | 96,704 | 9,613 | (2,037) | 4,487 | 400 | 7,166 | 145,792 | 937 | 146,729 |
| Loss for the period | - | - | (2,428) | - | - | - | - | (2,428) | (702) | (3,130) |
| Other comprehensive income (loss) | ||||||||||
| for the period | - | - | - | - | 655 | (1,960) | - | (1,305) | (1,477) | (2,782) |
| Total comprehensive income (loss) for | ||||||||||
| the period | - | - | (2,428) | - | 655 | (1,960) | - | (3,733) | (2,179) | (5,912) |
| Transactions with owners of the | ||||||||||
| Company, recognized directly in equity: |
||||||||||
| Buy of shares in subsidiaries from | ||||||||||
| non-controlling interests | - | - | - | - | - | - | (1,128) | (1,128) | 1,128 | - |
| Warrants exercise | 533 | 3,929 | - | - | - | - | - | 4,462 | - | 4,462 |
| Options exercise | 26 | - | - | - | - | - | - | 26 | - | 26 |
| Share-based payments | - | 8 | - | - | - | - | - | 8 | - | 8 |
| Balance as at | ||||||||||
| March 31, 2021 | 30,018 | 100,641 | 7,185 | (2,037) | 5,142 | (1,560) | 6,038 | 145,427 | (114) | 145,313 |
| For the three months ended March 31, | For the year ended December 31, |
For the three months ended March 31, |
|||
|---|---|---|---|---|---|
| 2021 | 2020 | 2020 | 2021 | ||
| Unaudited | Audited | Unaudited Convenience Translation into US\$* in thousands |
|||
| € in thousands | |||||
| Cash flows from operating activities | |||||
| Loss for the period | (2,666) | (1,865) | (6,168) | (3,130) | |
| Adjustments for: | |||||
| Financing expenses, net | 2,766 | 413 | 3,634 | 3,247 | |
| Profit from settlement of derivatives contract | (407) | - | - | (478) | |
| Depreciation and amortization | 3,051 | 726 | 2,975 | 3,581 | |
| Share-based payment transactions | 7 | 14 | 50 | 8 | |
| Share of profits of equity accounted investees | (617) | (1,331) | (1,525) | (724) | |
| Payment of interest on loan from an equity accounted investee | - | 582 | 582 | - | |
| Change in trade receivables and other receivables | (1,182) | 588 | (3,868) | (1,387) | |
| Change in other assets | 30 | (215) | 179 | 35 | |
| Change in receivables from concessions project | 221 | 201 | 1,426 | 259 | |
| Change in trade payables | (382) | 315 | 190 | (448) | |
| Change in other payables | 1,596 | (274) | (1,226) | 1,873 | |
| Income tax expense (tax benefit) | (319) | 104 | (125) | (374) | |
| Income taxes paid | - | - | (119) | - | |
| Interest received | 427 | 441 | 2,075 | 501 | |
| Interest paid | (1,206) | (168) | (3,906) | (1,415) | |
| 3,985 | 1,396 | 342 | 4,678 | ||
| Net cash from (used in) operating activities | 1,319 | (469) | (5,826) | 1,548 | |
| Cash flows from investing activities | |||||
| Acquisition of fixed assets | (25,653) | (41,414) | (128,420) | (30,106) | |
| Acquisition of subsidiary, net of cash acquired | - | - | (7,464) | - | |
| Compensation as per agreement with Erez Electricity Ltd. | - | - | 1,418 | - | |
| Repayment of loan from an equity accounted investee | - | 1,923 | 1,978 | - | |
| Loan to an equity accounted investee | (113) | - | (181) | (133) | |
| Advances on account of investments | - | - | (1,554) | - | |
| Settlement of derivatives | (252) | - | - | (296) | |
| Proceed from restricted cash, net | 454 | 22,585 | 23,092 | 533 | |
| Proceed from (investment) in short term deposit | 8,533 | - | (1,323) | 10,014 | |
| Proceeds from marketable securities | 1,785 | - | 1,800 | 2,095 | |
| Acquisition of marketable securities | - | - | (1,481) | - | |
| Net cash used in investing activities | (15,246) | (16,906) | (112,135) | (17,893) | |
| Cash flows from financing activities | |||||
| Issuance of warrants | - | 320 | 2,544 | - | |
| Acquisition of shares in subsidiaries from non-controlling interests | 1,400 | - | - | 1,643 | |
| Proceeds from options | 22 | - | 20 | 26 | |
| Cost associated with long term loans | (197) | - | (734) | (231) | |
| Proceeds from long term loans | 27,061 | 40,923 | 111,357 | 31,758 | |
| Repayment of long-term loans | (457) | (810) | (3,959) | (536) | |
| Repayment of Debentures | (21,877) | (22,162) | (26,923) | (25,674) | |
| Exercise of warrants | 3,675 | 13,188 | 21,275 | 4,313 | |
| Proceeds from issue of convertible debentures, net | 15,571 | - | - | 18,274 | |
| Proceeds from issuance of Debentures, net | 25,465 | - | 38,057 | 29,885 | |
| Net cash from financing activities | 50,663 | 31,459 | 141,637 | 59,458 | |
| Effect of exchange rate fluctuations on cash and cash equivalents | 1,439 | (828) | (1,340) | 1,688 | |
| Increase in cash and cash equivalents | 38,175 | 13,256 | 22,336 | 44,801 | |
| Cash and cash equivalents at the beginning of the period | 66,845 | 44,509 | 44,509 | 78,448 | |
| Cash and cash equivalents at the end of the period | 105,020 | 57,765 | 66,845 | 123,249 |
* Convenience translation into US\$ (exchange rate as at March 31, 2021: euro 1 = US\$ 1.174)
| PV | Total reportable |
Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Italy | Spain | Israel1 | Talasol | Biogas | Dorad | Manara | segments | Reconciliations | consolidated | |
| For the three months ended March 31, 2021 | ||||||||||
| € in thousands | ||||||||||
| Revenues | - | 784 | 832 | 3,0892 | 3,098 | 12,227 | - | 20,030 | (12,830) | 7,200 |
| Operating expenses | - | (132) | (81) | (611) | (2,393) | (9,279) | - | (12,496) | 9,279 | (3,217) |
| Depreciation and amortization | ||||||||||
| expenses | - | (237) | (574) | (1,915) | (771) | (1,212) | - | (4,709) | 1,658 | (3,051) |
| Gross profit (loss) | - | 415 | 177 | 563 | (66) | 1,736 | - | 2,825 | (1,893) | 932 |
| Project development costs | (505) | |||||||||
| General and | ||||||||||
| administrative expenses | (1,263) | |||||||||
| Share of profits (loss) of | ||||||||||
| equity accounted investee | 617 | |||||||||
| Operating loss | (219) | |||||||||
| Financing income | 912 | |||||||||
| Financing income | ||||||||||
| (expenses) in connection | ||||||||||
| with derivatives, net | (124) | |||||||||
| Financing expenses, net | (3,554) | |||||||||
| Loss before taxes | ||||||||||
| on Income | (2,985) | |||||||||
| Segment assets as at | ||||||||||
| March 31, 2021 | 588 | 18,244 | 35,543 | 237,886 | 36,282 | 113,366 | 42,859 | 484,768 | 6,879 | 491,647 |
1 The Talmei Yosef PV Plant located in Israel is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.
2Not including an amount of approximately €1 million of proceeds from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC).
| For the three months ended March 31, 2021 |
2020 | For the year ended December 31, 2020 |
For the three months ended March 31, 2021 |
|
|---|---|---|---|---|
| € in thousands | Convenience Translation into US\$* in thousands |
|||
| Net loss for the period | (2,666) | (1,865) | (6,168) | (3,130) |
| Financing expenses, net | 2,766 | 413 | 3,634 | 3,247 |
| Tax benefit (Taxes on income) | (319) | 104 | (125) | (374) |
| Depreciation | 3,051 | 726 | 2,975 | 3,581 |
| EBITDA | 2,832 | (622) | 316 | 3,324 |
* Convenience translation into US\$ (exchange rate as at March 31, 2021: euro 1 = US\$ 1.174)
Reconciliation of Segment Gross Profit to Segment Adjusted FFO
| Talasol PV Plant Israel – PV(1) |
|
|---|---|
| For the three months ended March 31, 2021 |
|
| Unaudited | |
| € in thousands | |
| Gross profit | 563 177 |
| General and administrative expenses | (138) (47) |
| Operating profit | 425 130 |
| Adjustment | 845(2) - |
| Adjusted operating profit | 1,270 - |
| Depreciation and amortization | 1,915 574 |
| Interest on loans | (1,425) (209) |
| Adjusted FFO | 1,760 495 |
___________________________ (1) Based on the segment results set forth above, which are adjusted to present the results of the Talmei Yosef PV Plant based on the fixed asset model and not as a financial asset under IFRIC 12.
(2) Results of the Talasol PV Plant for the period until January 27, 2021.
Reconciliation of Segment Gross Profit (Loss) to Segment FFO
| Netherlands – | ||
|---|---|---|
| Spain – PV | Biogas | |
| For the three months ended | ||
| March 31, 2021 | ||
| Unaudited | ||
| € in thousands | ||
| Gross profit (loss) | 509 | (66) |
| General and administrative expenses | (23) | (27) |
| Operating profit (loss) | 486 | (93) |
| Depreciation and amortization | 237 | 771 |
| Interest on loans | (69) | (109) |
| FFO | 654 | 569 |
Information for the Company's Debenture Holders
Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2021 and below.
Net Financial Debt
As of March 31, 2021, the Company did not have a Net Financial Debt, as the calculation of Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures), resulted in a negative amount (i.e., an excess of assets over liabilities) of approximately €(1.2) (consisting of approximately €242.81 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €103.82 million in connection with the Series C Debentures issuances (in July 2019, October 2020 and February 2021) and Series D Debentures issuance (in February 2021), net of approximately €105 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €242.83 million of project finance and related hedging transactions of the Company's subsidiaries).
1 Short-term and long-term debt from banks and other interest bearing financial obligations amount provided above, includes an amount of approximately €12.3 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet.
2 Debentures amount provided above, includes an amount of approximately €2.5 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet.
3 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).
Information for the Company's Series C Debenture Holders.
The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of March 31, 2021, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was approximately €123.8 million and (ii) the Company did not have a Net Financial Debt. In the event the Company does not have a Net Financial Debt the calculation of the two covenants that are based on Net Financial Debt (i.e., the ratio of the Company's Net Financial Debt to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) and the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA1), becomes irrelevant and the Company is therefore in compliance with such covenants.
The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended March 31, 20212 :
| For the four | |
|---|---|
| quarter period | |
| ended March 31, | |
| 2021 | |
| Unaudited | |
| € in thousands | |
| Loss for the period | (6,969) |
| Financing expenses, net | 5,987 |
| Taxes on income | (548) |
| Depreciation | 5,300 |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | 3,013 |
| Share-based payments | 43 |
| Adjusted EBITDA as defined the Series C Deed of Trust | 6,826 |
1 The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."
2 As noted above, the Company is in compliance with the covenant with respect to the ratio of Net Financial Debt to Adjusted EBITDA as the Company does not have a Net Financial Debt as of the end of the period. Therefore, the Adjusted EBITDA calculation above is provided for convenience and consistency purposes only.
Information for the Company's Series D Debenture Holders
The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2021, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €118.3 million and (ii) the Company did not have a Net Financial Debt. The Series D Deed of Trust provides that in the event the result of calculation of the Company's Net Financial Debt is a negative amount, the Company is and will be considered to have met the financial covenants that are based on the Net Financial Debt (i.e., the ratio of the Net Financial Debt to the Company's CAP, Net and the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA1).
The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 20212 :
| For the four quarter period ended March 31, 2021 |
|
|---|---|
| Unaudited | |
| € in thousands | |
| Loss for the period | (6,969) |
| Financing expenses, net | 5,987 |
| Taxes on income | (548) |
| Depreciation | 5,300 |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | 3,013 |
| Share-based payments | 43 |
| Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters3 | 12,366 |
| Adjusted EBITDA as defined the Series D Deed of Trust | 19,192 |
1 The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."
3 The adjustment is based on the results of the Talasol Project since January 27, 2021 and of the biogas plant in Gelderland since January 1, 2021. The results of the biogas plant in Gelderland were not included in the profit and loss statement of the Company for the year ended December 31, 2020.
2 As noted above, the Company is in compliance with the covenant with respect to the ratio of Net Financial Debt to Adjusted EBITDA as the Company does not have a Net Financial Debt as of the end of the period. Therefore, the Adjusted EBITDA calculation above is provided for convenience and consistency purposes only.